Normal Reference Values in Han Adults of Skin Thickness and Blood Flow by High-frequency Ultrasound (NOVAS-HFUS)

August 12, 2023 updated by: Chunyan Ma, First Hospital of China Medical University

Normal Reference Values in Han Adults of Skin Thickness and Blood Flow by High-frequency Ultrasound: a Multicenter Study in China

In recent years, high-frequency ultrasound has become a new non-invasive tool for the diagnosis of skin diseases, aesthetic medicine and preoperative and postoperative evaluation due to its higher resolution. The purpose of this multi-center Study is to establish the normal reference values of skin thickness and blood flow parameters by high-frequency ultrasound in Chinese Han adults, and to explore the influencing factors, so as to provide quantitative reference for the evaluation of facial skin aging degree and cosmetic treatment.

Study Overview

Status

Not yet recruiting

Conditions

Intervention / Treatment

Detailed Description

The skin is the body's largest organ and acts as a protective, permeable barrier against pathogen invasion and against chemical and physical attacks. Long-term exposure to solar ultraviolet radiation is a major factor in exogenous skin aging. With the gradual improvement of living standards and the development of medical cosmetology technology, Chinese consumers have gradually increased their acceptance of cosmetology consumption. Facial skin, as one of the important indicators of "beauty", has obviously received the attention of cosmetic surgeons and dermatologists. Skin thickness is one of the important indicators of facial aging. However, different gender, different parts of the skin thickness is very different, especially the facial skin, the thickness of the epidermis, dermis is different, and the facial plastic surgery, injection treatment, photoelectric treatment has a close relationship. In addition, the dermis is rich in blood vessels, especially in its deep layers, which play an important role in the nutritional support of tissues and homeostasis of the internal environment. With the increase of age, the degree of dermal vascularization decreases, which is also one of the factors affecting skin aging. Therefore, in aesthetic medicine, more accurate quantitative evaluation of skin thickness and blood flow rather than simple subjective evaluation is very important.

Ultrasound is a non-invasive imaging technique widely used in clinic. In recent years, with the development of ultrasound technology, the frequency of ultrasonic probes has been increasing. Because of its higher resolution, high-frequency ultrasound can clearly display the layer and structure of the skin, and achieve accurate measurement of skin thickness and evaluation of dermal blood flow. High-frequency ultrasound has become a new non-invasive tool for the diagnosis of skin diseases, aesthetic medicine and preoperative and postoperative evaluation. The purpose of this multi-center Study is to establish the normal reference values of skin thickness and blood flow parameters by high-frequency ultrasound in Chinese Han adults, and to explore the influencing factors, so as to provide quantitative reference for the evaluation of facial skin aging degree and cosmetic treatment.

Study Type

Observational

Enrollment (Estimated)

540

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Sampling Method

Probability Sample

Study Population

Chinese healthy Han adults

Description

Inclusion Criteria:

  1. Han nationality;
  2. Ages 18-79;
  3. Normal blood pressure (139-90/89-60mmHg);
  4. Body mass index < 30 kg/m2;
  5. Blood routine, fasting blood glucose, blood lipid, liver and kidney function, electrocardiogram were normal;
  6. No history of skin disease, connective tissue disease, cardiovascular disease, diabetes, severe liver and kidney dysfunction.
  7. No history of drug use affecting cardiovascular system.

Exclusion Criteria:

  1. People with skin diseases (such as eczema, psoriasis, scleroderma, etc.);
  2. Any skin disease at the test site (such as dermatitis, acne, breakages, previous skin lesions, etc.);
  3. chronic systemic diseases;
  4. Use corticosteroid drugs or immunosuppressants;
  5. Pregnant or lactating women;
  6. People who have been exposed to ultraviolet radiation for a long time or have a history of sun exposure within 3 months;
  7. The examined skin area has been previously treated with other methods;
  8. Unable to cooperate with the inspector.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Dermal thickness
Time Frame: 1 day
Dermal thickness reflects the change in skin structure and can be used to assess skin aging.
1 day

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Blood flow velocity of dermal artery
Time Frame: 1 day
Blood flow velocity of dermal artery reflects the hemodynamic changes of skin and can be used for early evaluation of skin aging.
1 day

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Lixin Jiang, PHD, Shanghai Jiao Tong University School of Medicine
  • Principal Investigator: Xinhua Ye, PHD, The First Affiliated Hospital with Nanjing Medical University
  • Principal Investigator: WeiDong Ren, PHD, Shengjing Hospital
  • Principal Investigator: Xin Guan, PHD, Tianjin Chest Hospital
  • Principal Investigator: Hongning Yin, PHD, The Second Hospital of Hebei Medical University
  • Principal Investigator: Xiaoshan Zhang, PHD, The Affiliated Hospital of Inner Mongolia Medical University
  • Principal Investigator: Yuhong Zhang, PHD, The Second Affiliated Hospital of Dalian Medical University
  • Principal Investigator: Qingxiong Yue, PHD, Dalian Municipal Central Hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

September 1, 2023

Primary Completion (Estimated)

September 30, 2024

Study Completion (Estimated)

September 30, 2025

Study Registration Dates

First Submitted

July 23, 2023

First Submitted That Met QC Criteria

August 12, 2023

First Posted (Actual)

August 21, 2023

Study Record Updates

Last Update Posted (Actual)

August 21, 2023

Last Update Submitted That Met QC Criteria

August 12, 2023

Last Verified

August 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • NOVAS-HFUS-01

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Healthy Volunteer

Clinical Trials on high-frequency ultrasound

Subscribe